INTRODUCTION
the hepatic phase are abdominal pain, fever, eosinophilia, and abnormal liver function tests (1, 2, 4) . The biliary phase usually presents with intermittent right upper quadrant pain with or without cholangitis or cholestasis (5, 6) . Diagnosis may be delayed because of the wide spectrum of the differential diagnosis and low incidence of F. hepatica infection (7) . Similar abnormal laboratory and radiological findings may represent viral hepatitis, liver abscess, malignancy, cholecystitis, sclerosing cholangitis, acquired immunodeficiency syndrome (AIDS)-related cholangitis, ruptured hydatid cyst, and parasites such as ascariasis and clonorchiasis (1, 3, 4) .
Human hydatid disease is caused by the larval form of the tapeworm genus Echinococcus. The most common form cystic hydatid disease results from infection with Echinococcus granulosus (EG). Although hydatid disease can develop anywhere in the human body, the liver is the most frequently involved organ (8) . Hepatic hydatid disease causes highly variable symptoms and signs, and can be found incidentally in an asymptomatic patient. The symptoms and signs may be caused by a toxic reaction to the parasite or by local and mechanical effects, depending on the location and nature of the cysts and the presence of complications. The clinical course of hepatic hydatid disease is nonspecific and varied. The diagnosis of hydatid disease is based on clinical findings, imaging techniques and serology (9) . The indirect immunofluorescence assay (IFA) is specific and sensitive, especially in cases of hepatic hydatidosis. IFA is the most sensitive test in more than 95% of patients with hepatic cystic hydatidosis (10).
The cross-reactivity between EG and F. hepatica infection has been reported previously (11) (12) (13) . Parasitic helminths express some antigen, which often accounts for serological cross-reactions. In the serodiagnosis, it is essential to inspect cross-reactivity between the target parasite and other parasites in order to assess diagnostic performance (13) .
The aim of this study was to determine the prevalence of anti-EG antibody in patients with F. hepatica infection.
MATERIALS AND METHODS

Study Population
This prospective study was conducted in the Gastroenterology and General Surgery Departments of Dicle University Hospital between January 2008 and December 2010. The study population consisted of the following groups: F. hepatica group, hydatid disease group and control group. All patients gave written informed consent, and the study was approved by the local ethics committee.
In all subjects, an initial complete clinical history, physical examination findings, and routine laboratory results including complete blood count and routine biochemical analysis were recorded. Contrast-enhancement abdominal computerized tomographic (CT) examination was performed in all patients with F. hepatica infection and hydatid disease. Abdominal ultrasound (US) examination was performed in all patients in the control group. All the CT scans were obtained using a four-channel multislice CT scanner (Sensation 4, Siemens Medical Solutions, Erlangen, Germany). A 3.75-MHz convex probe (Toshiba SSA-270 A, Tokyo, Japan) was used for US of the abdomen.
A specific indirect hemagglutination assay using purified adult F. hepatica F1 antigen (IHA, Laboratoires Fumouze Diagnostic, Levallois Perret, France; cut-off 1:320) was used for serological diagnosis of fascioliasis. The diagnosis of F. hepatica infection with hepatic phase was based on: (a) The presence of previously described characteristic findings on the abdominal CT examination (3, 14) and exclusion of all known diseases that cause hepatic lesion seen on CT examination; (b) the positive specific IHA for F. hepatica; (c) and/or the presence of eggs of F. hepatica in the fecal examination. The diagnosis of F. hepatica infection with biliary phase was based on the extraction of living F. hepatica during endoscopic retrograde cholangiopancreatography (ERCP).
The IFA for EG was performed using frozen sections of EG larvae (Euroimmun, Medizinische Labordiagnostika AG kit; cut-off 1/100) to determine the presence of IgA, IgG or IgM antibody in all subjects as previously described (10) . The diagnosis of hydatid disease was confirmed by characteristic CT findings before surgery (8, 9) and typical hydatid cystic appearance during surgery.
Patients who were followed for routine check-ups and were without any disease were included in the study as the control group.
Statistical Analysis
Comparison of laboratory features, age and gender between groups was done. Results are expressed as mean ± standard error (SE) (range) or num-ber (proportion) of patients. Chi-square test and Fisher's exact test were used for comparison of numerical values. Mann-Whitney U test was used for comparison of the mean of numerical values. P values were considered statistically significant at p≤0.05. Table 1 shows the initial demographic and laboratory features of all groups. During the study period, 25 patients were diagnosed as F. hepatica infection. In 18 patients, the diagnosis of fascioliasis was based on positive IHA (≥1/620) test and characteristic abdominal CT findings. The mean titer of IHA for F. hepatica was 1/2720±549 (range: 1/640-5120). These patients were accepted as the hepatic phase of fascioliasis. In the remaining 7 patients, diagnosis of fascioliasis was confirmed by extraction of living mobile F. hepatica from extrahepatic biliary ducts during the ERCP procedure. These patients were accepted as biliary phase of fascioliasis. Microscopic examination of fecal specimens for eggs of F. hepatica revealed a positive result in only 2 of 25 patients (1 biliary and 1 hepatic phase). After confirmation of fascioliasis, triclabendazole was administered at a dose of 10-12 mg/kg for 1 day in all patients. Six months after treatment, there was complete clinical and laboratory improvement in all patients. We excluded 3 patients with hepatic phase of fascioliasis from the study because of the absence of IFA kit for EG antibody during their admission to our hospital. The remaining 22 patients were included in the study. IFA for EG was positive in 10 of 15 (66%) patients with hepatic phase and in 3 of 7 (42%) patients with biliary phase. The antibody titer was 1/100 in 6 patients and 1/320 in 7 patients. The mean antibody titer was 1/129±29 (range: 0-1/320).
RESULTS
There were 22 patients in the hydatid disease group. The hydatid cyst was located in the right lobe of the liver in 14 patients, left lobe in 3 patients, and both lobes in 4 patients and in the spleen in 1 patient. The number of cysts was one in 14 patients, two in 6 patients and three in 2 patients. According to the Gharbi classification (K-31), cysts were type II in 3 patients, type III in 11 patients, and type IV in 8 patients. The patient with splenic hydatid cyst had one type IV cyst. The mean cyst diameter was 9.63±0.83 (range: 4-18) cm. IFA for EG antibody was positive in all patients. The mean antibody titer was 1/342±61 (range: 1/100-1000). It was 1/100 in 7 patients, 1/320 in 12 patients and 1/1000 in 3 patients.
There were 24 subjects in the control group. Abdominal US showed no mass lesion in any of the patients. IFA for EG was positive in 2 female subjects. The antibody titer was 1/100 in both subjects.
Comparison of Groups
The positivity rate of IFA for EG was significantly higher in the hydatid disease group compared to the fascioliasis group (100% vs 59%, respectively; p<0.001). Mean alanine aminotransferase (ALT), aspartate aminotransferase (AST) and eosinophil count were significantly higher in the F. hepatica group compared to the hydatid disease group (p=0.021; p=0.026; p=0.02, respectively). There was no significant difference between the F. hepatica group and the hydatid disease group regarding white blood cell (WBC) count, alkaline phosp- hatase, gamma glutamyl transferase (GGT), and total bilirubin level.
The positivity rate of IFA for EG was significantly higher in the hydatid disease group compared to the control group (100% vs 8.3%; p<0.001). There was no significant difference between the hydatid disease group and the control group regarding total WBC count, ALT, AST, GGT, and total bilirubin level. Mean alkaline phosphatase and eosinophil count were significantly higher in the hydatid disease group compared to the control group (p=0.026 and p=0.008, respectively).
The positivity rate of IFA for EG was significantly higher in the F. hepatica group compared to the control group (59% vs 8.3%; p=0.001). Total WBC count, eosinophil count, ALT, AST, alkaline phosphatase, and GGT level were significantly higher in the F. hepatica group compared to the control group (p<0.001 for all parameters). There was no significant difference between the F. hepatica group and the control group regarding total bilirubin level.
DISCUSSION
Parasitic helminths express various antigenic carbohydrates, which often account for serological cross-reactions. In the serodiagnosis, it is essential to inspect cross-reactivity between the target parasite and other parasites in order to assess diagnostic performance. The Gal (ß1-6) Gal sequence is a common epitope between EG and F. hepatica (13). Wuhrer et al. (15) reported that F. hepatica exhibits mammalian-type glycolipids as well as Gal (ß1-6) Gal-terminating glycolipids that account for cestode serological cross-reactivity. Ramzy et al. (12) reported that 5% of healthy people have IgG3 antibody and 10% of healthy people have IgG4 antibody for EG. Cross-reactivity has been observed with total IgG antibody followed by that of IgG4 in the sera from cases with trichostrongyliasis, ancylostomiasis, schistosomiasis, ascariasis, and fascioliasis. In this study, we showed that IFA for EG was positive in 59% of patients with fascioliasis and 8.3% of healthy people. All these positive results were in low titers (≤1/320). The high incidence of positive IFA test for EG in patients with fascioliasis may be related to the antigenic similarity between F. hepatica and EG, but positive results in healthy people may be related to past exposure to EG. The high incidence of cross-reactivity especially in low titers between parasites can suggest that serological tests without additional confirmatory tests such as characteristic radiological findings are not a reliable method for diagnosis of these infections. The important limitation of this study is that we did not investigate the presence of antibody titers of F. hepatica in the patients with hydatid disease. The presence of common antigens in F. hepatica and EG may also suggest the presence of antibody against F. hepatica in EG infection.
Typical organ lesion(s) detected by imaging techniques (e.g. US, CT), specific serum antibodies assessed by high-sensitivity serological tests, histopathology or parasitology compatible with EG, and detection of pathognomonic macroscopic morphology of cyst(s) in surgical specimens confirm the diagnosis of EG (9) . Routine laboratory tests are not specific for the diagnosis of hydatid disease and may reveal normal or abnormal values. Screening tests such as IHA, enzyme-linked immunosorbent assay (ELISA) and latex agglutination using crude antigens are associated with a high incidence of false-negative and false-positive results (8) . The parasitic antigens of major diagnostic value are antigen 5 (arc-5) and antigen B (8, 16) . Purified fractions enriched in antigens 5 and B and glycoproteins from hydatid fluid yielded a sensitivity rate of 95%, with a specificity rate of 100% (17) . The diagnosis of hydatid disease was confirmed in all our patients by positive IFA test, CT findings and pathognomonic surgical findings.
Diagnosis of fascioliasis may be delayed because of the wide spectrum of the differential diagnosis and low incidence of F. hepatica infection (3). Similar abnormal laboratory and radiological findings may represent viral hepatitis, liver abscess, malignancy, cholecystitis, sclerosing cholangitis, AIDS-related cholangitis, ruptured hydatid cyst, and parasites such as ascariasis and clonorchiasis (1, 3) . The specificity of the IHA method using purified adult F. hepatica antigen F1 for serological diagnosis of F. hepatica is 96.9% (18) . Diagnosis is confirmed only by demonstrating the parasites or its egg in the bile or feces (1,3) . Negative stool examinations do not rule out the disease (3, 7) . A high index of suspicion and specific radiological findings including tunnel-like tracts extending towards the capsule and multiple, hypodense, linear or branching lesions on CT are very helpful in the diagnosis of fascioliasis. We suspected the possibility of fascioliasis in all patients with hepatic phase because of eosinophilia and characteristic CT findings. We found eggs in the stool sample of 1 of 16 patients with hepatic phase and 1 of 7 patients with biliary phase. Complete clinical, laboratory and radiological response after triclabendazole administration associated with positive result in high titer of IHA against F. hepatica confirmed the diagnosis in patients with hepatic phase of F. hepatica infection. Diagnosis in the patients with biliary phase was confirmed by extraction of living F. hepatica from bile ducts.
In conclusion, cross-reactions are an important issue in the serological diagnosis of parasitic infections. IFA for EG is positive in the majority of patients with F. hepatica infection and in some healthy subjects. In clinical practice, IFA for EG is not a reliable serological diagnostic method for differentiation of hydatid disease from fascioliasis.
